L04AA Selective immunosuppressants

PheWeb

RX_L04AA

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L04AA

6434

Check pre-conditions, main-only, mode, ICD version None

5255

Check minimum number of events

Min. number of events 3

5255

Include endpoints None

5255

RX_L04AA

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L04AA Selective immunosuppressants based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5083	3171	1912
Unadjusted prevalence (%)	1.65	1.83	1.42
Mean age at first event (years)	49.18	48.76	49.87

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.90 [1.28, 2.81]	1.4e-3	324
15 years	0.01	1.50 [1.05, 2.15]	2.6e-2	174
5 years	0.00	2.92 [2.12, 4.01]	4.1e-11	86
1 year	0.00	3.21 [1.91, 5.39]	1.1e-5	18

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L04AA – L04AA Selective immunosuppressants
GWS hits:

Survival analyses between endpoints

↥

Plot

before L04AA Selective immunosuppressants
after L04AA Selective immunosuppressants

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L04AA Selective immunosuppressants

↥